🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
451
$4519.T
🔒 Asia-PacificCHUGAI PHARMACEUTICAL CO
AVG HISTORICAL GAP
-0.43%
MAX GAP RECORD
-9.99%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $4519.T
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$4519.T
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 27, 2026 Earnings Release 2026-10-27 (BEFORE OPEN) |
-1.45%
|
| Jul 24, 2026 Earnings Release 2026-07-24 (AFTER CLOSE) |
-4.87%
|
| Apr 24, 2026 Earnings Release 2026-04-24 (AFTER CLOSE) |
-9.99%
|
| Jan 29, 2026 Earnings Release 2026-01-29 (BEFORE OPEN) |
-1.28%
|
| Oct 24, 2025 Earnings Release 2025-10-24 (AFTER CLOSE) |
-0.89%
|
| Jul 24, 2025 Earnings Release 2025-07-24 (AFTER CLOSE) |
+0.07%
|
| Apr 24, 2025 Earnings Release 2025-04-24 (AFTER CLOSE) |
+3.49%
|
| Jan 30, 2025 Earnings Release 2025-01-30 (AFTER CLOSE) |
+3.14%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.8%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (6)
📖 Intelligence Summary
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. It offers oncology products, such as Alecensa, Avastin, FoundationOne, Herceptin, Kadcyla, Lunsumio, Perjeta, Phesgo, Polivy, and Tecentriq; Actemra for humanized anti-human IL-6 receptor monoclonal antibody; CellCept,…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗